VIDEO: Venetoclax/rituximab prolongs PFS in relapsed/refractory CLLDecember 12, 2017Leukemia, Myelodysplasia, Transplantation
Azacitidine maintenance improves PFS in older AML patientsDecember 11, 2017Leukemia, Myelodysplasia, Transplantation
Flu vaccine did not protect children with acute leukemiaDecember 11, 2017Leukemia, Myelodysplasia, Transplantation
CLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLLDecember 10, 2017Leukemia, Myelodysplasia, Transplantation
Avapritinib yields high response rate in patients with systemic mastocytosisDecember 10, 2017Leukemia, Myelodysplasia, Transplantation
ASCO platelet transfusion guidelines updatedDecember 4, 2017Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Researchers identify potential gene target for AML drug developmentNovember 28, 2017Leukemia, Myelodysplasia, Transplantation
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Start with fitness when deciding on treatment for elderly AML patientsNovember 20, 2017Leukemia, Myelodysplasia, Transplantation
Studies need to address best follow-on therapy to ibrutinib in CLLNovember 18, 2017Leukemia, Myelodysplasia, Transplantation
Cancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareGastroenterologyLeukemia, Myelodysplasia, TransplantationLung CancerRenal Cell CarcinomaHead & Neck/Thyroid CancersBreast Cancer
FDA approves dasatinib for pediatric Ph+ CMLNovember 14, 2017Leukemia, Myelodysplasia, Transplantation
In children with ALL, physical and emotional effects persistNovember 13, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPatient & Survivor Care
FDA approves first Erdheim-Chester disease treatmentNovember 6, 2017Rare DiseasesLeukemia, Myelodysplasia, Transplantation